We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Beckman Coulter Partners With South West London Pathology To Reduce the Impact of Sepsis In the UK

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Beckman Coulter Partners With South West London Pathology To Reduce the Impact of Sepsis In the UK"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Beckman Coulter, a company specializing in clinical diagnostics, has announced that South West London Pathology (SWLP) has implemented DxH 900 hematology analyzers and the Early Sepsis Indicator across the SWLP network. SWLP is an award-winning NHS pathology partnership set up by St. George’s University Hospitals NHS Foundation Trust, Croydon Health Services NHS Trust and Kingston Hospital NHS Foundation Trust. The installation enables SWLP laboratories to provide a single, integrated pathology service to more than 3.5 million people across South West London via three hospitals, 200 GP practices and 30 community healthcare sites.

Beckman Coulter’s DxH 900 hematology analyzers are designed to enable clinical laboratories like SWLP to perform complete blood count and white blood cell differential tests. Demonstrating 93% first-pass yield, the DxH 900 aims to reduce the number of manual slide reviews, helping to generate reportable results as quickly as possible. In addition, the DxH 900 features the Early Sepsis Indicator, a CE marked and FDA-cleared hematologic biomarker that aids the diagnosis of sepsis in adult patients.